For patients with advanced oropharyngeal cancer, proton therapy may beat photon radiotherapy in terms of overall survival and ...
SAN FRANCISCO, September 29, 2025 — A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low ...
Bone marrow-sparing radiotherapy represents an evolving strategy in the management of cervical cancer, aiming to minimise inadvertent irradiation of the bone marrow and, consequently, reduce the ...
Intensity-modulated radiotherapy is as good as proton beam therapy for treating people with head and neck cancer, according to the results of a Cancer Research UK-funded clinical trial. The TORPEdO ...
TUESDAY, Dec. 30, 2025 (HealthDay News) -- For patients with stage III or IV oropharyngeal cancer, intensity-modulated proton therapy (IMPT) is noninferior to intensity-modulated radiation therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback